Skip to Main Content

Author Details

Qi Wu
University of Michigan Medical School
1989
71
30
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36442285The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters.Int Immunopharmacol2023
36442285The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters.Int Immunopharmacol2023
37806231Dysregulation of humoral immunity, iron homeostasis, and lipid metabolism is associated with multiple sclerosis progression.Mult Scler Relat Disord2023
37467700MOG-specific T cell response amplified in para- and post-SAR-CoV-2 infection in myelin oligodendrocyte glycoprotein antibody-associated disease.J Neuroimmunol2023
37172367Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis.Mult Scler Relat Disord2023
37806231Dysregulation of humoral immunity, iron homeostasis, and lipid metabolism is associated with multiple sclerosis progression.Mult Scler Relat Disord2023
37467700MOG-specific T cell response amplified in para- and post-SAR-CoV-2 infection in myelin oligodendrocyte glycoprotein antibody-associated disease.J Neuroimmunol2023
37172367Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis.Mult Scler Relat Disord2023
35949588Connexin 43 overexpression induces lung cancer angiogenesis <i>in vitro</i> following phosphorylation at Ser279 in its C-terminus.Oncol Lett2022
35447415MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice.Mol Immunol2022
35949588Connexin 43 overexpression induces lung cancer angiogenesis <i>in vitro</i> following phosphorylation at Ser279 in its C-terminus.Oncol Lett2022
35682558Current and Future Biomarkers in Multiple Sclerosis.Int J Mol Sci2022
35447415MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice.Mol Immunol2022
35682558Current and Future Biomarkers in Multiple Sclerosis.Int J Mol Sci2022
34483021Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.Vaccine2021
34720605Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis.J Cent Nerv Syst Dis2021
34483021Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.Vaccine2021
34720605Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis.J Cent Nerv Syst Dis2021
32198230Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing.Neurol Neuroimmunol Neuroinflamm2020
32198230Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing.Neurol Neuroimmunol Neuroinflamm2020
31935197Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.JCI Insight2020
32503977Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.Nat Commun2020
32554431IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.J Immunol2020
31935197Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.JCI Insight2020
32554431IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice.J Immunol2020
32503977Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.Nat Commun2020
31222050Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation.Sci Rep2019
31745200Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation.Sci Rep2019
31222050Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation.Sci Rep2019
31745200Author Correction: Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation.Sci Rep2019
30201809Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.J Immunol2018
30201809Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.J Immunol2018
28577989Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity.Neurochem Int2017
28904124Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.J Immunol2017
28577989Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity.Neurochem Int2017
29206103A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice.Elife2017
28258191Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.J Immunol2017
28258191Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.J Immunol2017
29206103A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice.Elife2017
28904124Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.J Immunol2017
27006972Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.Neurol Neuroimmunol Neuroinflamm2016
27006972Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.Neurol Neuroimmunol Neuroinflamm2016
25429066A critical role for the regulated wnt-myc pathway in naive T cell survival.J Immunol2015
25888644General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice.J Immunol2015
25429066A critical role for the regulated wnt-myc pathway in naive T cell survival.J Immunol2015
25639470An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation.Mol Cell2015
26098211Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus.J Clin Invest2015
26090715Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.Int J Mol Sci2015
26098211Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus.J Clin Invest2015
26090715Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.Int J Mol Sci2015
  • 1 - 50 of 142

Recommended Authors

University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 3
Peking University
Career Start Year 2009
Number of shared co-authors 0
University of Illinois College of Medicine Rockford
Career Start Year 2007
Number of shared co-authors 2
University of California san francisco
Career Start Year 2006
Number of shared co-authors 0
Pennsylvania State University College of Medicine
Career Start Year 2002
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
University of California San Diego
Career Start Year 1999
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Near-InfraRed Photo-Immunotherapy Research Institute, Kansai Medical University
Career Start Year 1996
Number of shared co-authors 0
University of Perugia
Career Start Year 1995
Number of shared co-authors 0
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1995
Number of shared co-authors 1
TUM School of Medicine, Technical University of Munich
Career Start Year 1993
Number of shared co-authors 2
The University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 2
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 1990
Number of shared co-authors 0
University of California san francisco
Career Start Year 1990
Number of shared co-authors 1
University of Florida College of Medicine
Career Start Year 1989
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
University of Perugia
Career Start Year 1988
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1988
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
Genentech Inc.
Career Start Year 1983
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
Yale School of Medicine, Yale School of Public Health
Career Start Year 1981
Number of shared co-authors 1
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1980
Number of shared co-authors 1
University of Massachusetts School of Medicine
Career Start Year 1976
Number of shared co-authors 0
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 1
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0
University of British Columbia
Career Start Year 1965
Number of shared co-authors 0

Collaborators

University of Alabama at Birmingham and Birmingham VA Medical Center.
Co-authored papers 41
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Co-authored papers 39
University of Texas MD Anderson Cancer Center
Co-authored papers 37
Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University
Co-authored papers 9
University of Alabama at Birmingham
Co-authored papers 6
University of Alabama at Birmingham
Co-authored papers 4
University of Alabama at Birmingham Birmingham
Co-authored papers 3
University of Tennessee Health Science Center
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
Merck & Co., Inc.
Co-authored papers 2
University of California San Diego
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 1
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
University of Michigan ann arbor
Co-authored papers 1
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 1
Co-authored papers 1
University of Alabama
Co-authored papers 1
La Jolla Pharmaceutical Company
Co-authored papers 1
Hospital for Special Surgery and Weill Cornell Medical College
Co-authored papers 1
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Informatics Institute, the University of Alabama at Birmingham
Co-authored papers 1
Co-authored papers 1
Mayo Clinic Vaccine Research Group
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Co-authored papers 1
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 1